-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Brodalumab (Brodalumab) is a fully humanized monoclonal antibody with a unique mechanism of action that binds to IL-17 receptor subunits.
Conclusion: Compared with placebo, Pedaluzumab is associated with rapid and significant improvement in the signs and symptoms of PsA
Compared with placebo, Pedaluzumab is associated with rapid and significant improvement in the signs and symptoms of PsA
Leave a message here